![This Vaccine Stock Soars 46% After $1.1 Billion AstraZeneca Deal](https://cdn.newsserve.net/ONPglobe256.png)
This Vaccine Stock Soars 46% After $1.1 Billion AstraZeneca Deal
Icosavax stock soared 46% in Tuesday premarket trading after the Seattle-based vaccine developer reached a deal to be acquired by pharmaceutical giant AstraZeneca.
#seattle #astrazeneca